Chronic exposure to opioid agonists and antagonists affects prodynorphin gene expression
Romualdi, P.; Lesa, G.; Ferri, S.
Acta Physiologica Hungarica 75 Suppl: 247-248
1990
ISSN/ISBN: 0231-424X PMID: 2371879 Document Number: 353360
Document emailed within 1 workday
Related Documents
Holzgrabe, U.; Nachtsheim, C.; Siener, T.; Drosihn, S.; Brandt, W. 1997: Opioid agonists and antagonists, opioid receptors Die Pharmazie 52(1): 4-22Cserpán, E.; Tryoen-Tóth, P.; Bajenaru, L.; Benyhe, S.; Maderspach, K. 1997: Differential expression of the K-2 opioid receptor protein under the effect of opioid agonists in embryonic chick neurons in vitro Neurobiology 5(2): 233-248
Kotlińska, J.; Langwiński, R. 1990: The lack of effect of opioid agonists and antagonists on some acute effects of ethanol Polish Journal of Pharmacology and Pharmacy 42(2): 129-135
Spasojevic, N.; Jovanovic, P.; Dronjak, S. 2012: Chronic fluoxetine treatment affects gene expression of catecholamine enzymes in the heart of depression model rats Indian Journal of Experimental Biology 50(11): 771-775
Winger, G.; Skjoldager, P.; Woods, J.H. 1992: Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys Journal of Pharmacology and Experimental Therapeutics 261(1): 311-317
Liao, P.-A.; Pan, S.-W.; Chen, C.-Y.; Deng, C.-Y.; Dong, Y.-H. 2023: Prescription Patterns of new use of Fixed-Dose Combination Inhalers in Patients with Chronic Obstructive Pulmonary Disease: Long-Acting β2 Agonists Plus Long-Acting Muscarinic Antagonists versus Long-Acting β2 Agonists Plus Inhaled Corticosteroids International Journal of Chronic Obstructive Pulmonary Disease 18: 553-563
Ferry, R.C.; Unsworth, C.D.; Molinoff, P.B. 1993: Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells Molecular Pharmacology 43(5): 726-733
Gulati, K.; Ray, A.; Sharma, K.K. 1992: Effects of acute or chronic opioid agonists and their modulation by diurnal rhythmicity and satiety states on food intake in rats Indian Journal of Experimental Biology 30(3): 185-189
Shi, C.Z.; Li, X.M.; Liu, Y.; Zhang, J.T. 1990: Application of mouse tail artery for the study of alpha adrenoceptor agonists and antagonists and calcium antagonists Yao Xue Xue Bao 25(3): 223-226
Sofuoglu, M.; Portoghese, P.S.; Takemori, A.E. 1991: Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes Journal of Pharmacology and Experimental Therapeutics 257(2): 676-680
Schreiber, R.; Brocco, M.; Audinot, V.; Gobert, A.; Veiga, S.; Millan, M.J. 1995: (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists Journal of Pharmacology and Experimental Therapeutics 273(1): 101-112
Lancillotti, F.; Giandomenico, V.; Affabris, E.; Fiorucci, G.; Romeo, G.; Rossi, G.B. 1995: Interferon alpha-2b and retinoic acid combined treatment affects proliferation and gene expression of human cervical carcinoma cells Cancer Research 55(14): 3158-3164
Charness, M.E.; Hu, G.; Edwards, R.H.; Querimit, L.A. 1993: Ethanol increases delta-opioid receptor gene expression in neuronal cell lines Molecular Pharmacology 44(6): 1119-1127
Fu, J.; Chen, Z.; Cen, J.; Ruan, C. 2000: Expression of the human multidrug resistance gene mdr1 in leukemic cells and its application in studying P-glycoprotein antagonists Chinese Medical Journal 113(3): 228-231
Ray, S.B.; Gupta, Y.K.; Wadhwa, S. 2005: Expression of opioid receptor-like 1 (ORL1) and mu opioid receptors in the spinal cord of morphine tolerant mice Indian Journal of Medical Research 121(3): 194-202
Rónai, A.Z.; Botyánszki, J.; Magyar, A.; Borsodi, A.; Benyhe, S.; Medzihradszky, K. 1993: Novel, delta-opioid receptor-selective peptide antagonists: demonstration of a possible opioid interaction in the absence of a protonated nitrogen and attempts to locate the protonated nitrogen site Archives Internationales de Pharmacodynamie et de Therapie 323: 114-125
Ferrari, S.; Tagliafico, E.; Ceccherelli, G.; Selleri, L.; Calabretta, B.; Donelli, A.; Temperani, P.; Sarti, M.; Sacchi, S.; Emilia, G. 1989: Expression of the myeloperoxidase gene in acute and chronic myeloid leukemias: relationship to the expression of cell cycle-related genes Leukemia 3(6): 423-430
Hirning, L.D.; Peterson, L.J.; Burks, T.F. 1985: Comparison of mu opioid agonists in vitro Proceedings of the Western Pharmacology Society 28: 111-113
Nosov, M.A.; Barabanova, S.V.; Glushikhina, M.S.; Kazakova, T.B.; Korneva, E.A. 2001: Cell activation in the hypothalamus after exposure to an antigen (based on c-fos gene expression) Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 87(3): 331-340
Fox, T.R.; Best, L.L.; Goldsworthy, S.M.; Mills, J.J.; Goldsworthy, T.L. 1993: Gene expression and cell proliferation in rat liver after 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure Cancer Research 53(10 Suppl): 2265-2271